Tumor sections were also analyzed for T-cell infiltration, demonstrating an increased number of CD8+ and CD4+ T lymphocytes in the (M23 + R848)PLGA vaccination group (Figure 8C,D). This evidence concerns the gene CD8A and neoplasm.